öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÐ»ÒãÇ¿
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º176

ËùÊôԺУ£ºº£ÄÏҽѧԺ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ
Ñо¿ÁìÓò£º ÖÐÒ½Ò©·ÀÖÎÄÚ·ÖÃÚ¼°´úл¼²²¡µÄÒ©ÀíÑо¿
Ñо¿ÁìÓò£º ÖÐÒ½Ò©·ÀÖÎÄÚ·ÖÃÚ¼°´úл¼²²¡µÄÒ©ÀíÑо¿ [ÊÕÆð]




¸öÈ˼òÊö :
ÏÖÈκ£ÄÏҽѧԺ¿ÆÑд¦¸±´¦³¤£¬¿ÆÑÐÖ±Êôµ³Ö§²¿Êé¼Ç£¬º£ÄÏҽѧԺУ¼¶Öصã·ö³Öѧ¿ÆÖÐÎ÷Ò½½áºÏÁÙ´²Ñ§¿Æ´øÍ·ÈË£¬º£ÄÏÊ¡515 È˲Ź¤³ÌµÚ¶þ²ã´ÎÈËÑ¡£¬º£ÄÏÊ¡ÓÐÍ»³ö¹±Ï×µÄÓÅÐãר¼Ò£¬º£ÄÏÊ¡¸ßУÓÅÐãÖÐÇàÄê¹Ç¸É½Ìʦ£¬¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾ÖÖÐÒ½¸Îµ¨²¡Öصãѧ¿Æºó±¸Ñ§¿Æ´øÍ·ÈË¡£Ö÷ÒªÑо¿ÌÇÄò²¡¼°Æä²¢·¢Ö¢µÄÖÐÒ½²¡ÀíÉúÀíÒÔ¼°ÖÐÒ½Ò©·ÀÖΡ£ 2012 Äê»ñµÃº£ÄÏÊ¡ÇàÄêÎåËĽ±Õ¡£Ö÷Òª´ÓÊÂÖÐÒ½Ò©·ÀÖÎÌÇÄò²¡Ñª¹Ü²¡±ä¼°ÌÇÄò²¡Éö²¡µÄÉúÀí²¡Àí¡£ÔÚÌÇÄò²¡µÄÖÐÒ½Ö¤ºò·ÖÐÍÓë»ùÒò¶à̬ÐÔµÄÑо¿¡¢ÄÏÒ©ÒæÖÇÈʼ°¶ÔÒ©¶ÔÌÇÄò²¡Éö²¡·ÀÖεÄҩЧѧ¡¢Ò©Àíѧ¼°×÷ÓûúÖƺͰеãÓÐÒ»¶¨µÄÑо¿¡£ÀûÓú£ÄÏÌØÓеÄÄÏÒ©ÀèÒ©µÄ×ÊÔ´ÓÅÊÆ£¬¿ªÕ¹ÌØÉ«Ò©ÎïÒæÖÇÈÊ·ÀÖÎÌÇÄò²¡Éö²¡µÄ»úÖÆÑо¿£¬Îª´«Í³Ò½Ò©µÄÏÖ´ú»¯ºÍ²úÒµ»¯×ª»¯µì¶¨ÀíÂÛ»ù´¡£¬È¡µÃÁ˽׶ÎÐԳɹû£¬Ö¤ÊµÁËÒæÖÇÈʶÔÌÇÄò²¡Éö²¡·ÀÖεÄÓÐЧÐÔ£¬²¢´ÓˮͨµÀµ°°×£¬miRNA-21»ùÒò¼×»ù»¯£¬Ñõ»¯Ó¦¼¤µÈ·½Ãæ֤ʵÁËÒæÖÇÈʼ°ÆäÅäÎé²úÎï·ÀÖÎÌÇÄò²¡Éö²¡µÄ»úÖÆ¡£ÏÖÖ÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð2Ïº£ÄÏÊ¡¿ÎÌâ2ÏÔÚÑо­·Ñ½ü150 ÍòÔª£¬½ü3 ÄêÀ´ÒÔµÚÒ»×÷Õß·¢±íÂÛÎÄ 15ƪ£¬ÆäÖÐ SCI ÊÕ¼3 ƪ£¬»ñµÃº£ÄÏÊ¡¿Æ¼¼½ø²½ÈýµÈ½±1ÏÉ걨 2Ïî·¢Ã÷רÀû¡£

¿ÆÑй¤×÷ :
[1]YI-QIANG XIE, HUA WANG, YUE-PING WU,et al. Association of APOE polymorphisms and insulin resistance with TCM syndromes in type 2 diabetes patients with macroangiopathy[J]. Molecular Medicine Reports,2011, 4: 1219-1223.£¨SCIÊÕ¼£©
[2] Yi-Qiang Xie£¬Xian-bo Wu.Lentinan treatment of Plasmodium yoelii-infected mice induces apoptosis of regulatory T cells[J]. African Journal of Biotechnology£¬2012 £¬11(9)£º 2371-2375.
[3] Suchun Yan, Yiqiang Xie, Bide Zhu, et al. Effect Comparison of different formulation of Dang-Gui-Bu-Xu-Tang on myelosuppression mouse. [J]. Asian Pacific Journal of Tropical Medicine ,2011,4(7): 556-559. £¨SCIÊÕ¼ ͨѶ×÷Õߣ©
[4]Yi-Qiang Xie, Xian-Bo Wu, Song-Qi Tang.Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts. Int J Clin Exp Med 20147(1):108-114.£¨SCIÊÕ¼£©
[5]лÒãÇ¿,Íõ»ª,ÎâÔÂƽ,µÈ.2ÐÍÌÇÄò²¡´óѪ¹Ü²¡±ä»¼ÕßÖ¬´úлÎÉÂÒÓëApoE»ùÒò¶à̬ÐÔ¼°ÖÐÒ½Ö¤ºòµÄÑо¿[J]. ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2011£¬26£¨1£©£º144-146.£¨ÖÐÎĺËÐÄÆÚ¿¯£©
[6]лÒãÇ¿,Íõ»ª,ÎâÔÂƽ,µÈ. 2ÐÍÌÇÄò²¡´óѪ¹Ü²¡±ä»¼ÕßApoE»ùÒò¶à̬ÐÔÓëÖÐÒ½Ö¤ºòµÄÏà¹ØÐÔÑо¿[J]. ʱÕä¹úÒ½¹úÒ©£¬2011£¬22£¨1£©£º221-223. £¨ÖÐÎĺËÐÄÆÚ¿¯£©
[7]лÒãÇ¿,ÎâÔÂƽ,ÒüµÂ»Ô,µÈ. 2ÐÍÌÇÄò²¡´óѪ¹Ü²¡±ä»¼ÕßÖÐÒ½Ö¤ºò·Ö²¼µÄÑо¿[J].ÁÉÄþÖÐÒ½ÔÓÖ¾,2010,37(10):1875-1876. £¨ÖÐÎĺËÐÄÆÚ¿¯£©
[8]лÒãÇ¿,Íõ»ª,ÎâÔÂƽ,µÈ. 2ÐÍÌÇÄò²¡´óѪ¹Ü²¡±ä»¼ÕßÒȵºËصֿ¹ÓëÖÐÒ½Ö¤ºòµÄÏà¹ØÐÔÑо¿[J].ʱÕä¹úÒ½¹úÒ©£¬2010£¬21£¨10£©£º2610-2612. £¨ÖÐÎĺËÐÄÆÚ¿¯£©
[9]лÒãÇ¿,»ÆÔª»ª,Ðìö©,µÈ. ¶àÄÒÂѳ²×ÛºÏÕ÷»¼ÕßÖÐÒ½Ö¤ºò·Ö²¼µÄÑо¿[J].ÁÉÄþÖÐÒ½ÔÓÖ¾,2009,36(2):172-173. £¨ÖÐÎĺËÐÄÆÚ¿¯£©
[10]лÒãÇ¿,»ÆÔª»ª,Ðìö©,µÈ.ÒȵºËصֿ¹Óë¶àÄÒÂѳ²×ÛºÏÕ÷¹ØϵµÄÑо¿½øÕ¹[J].½­ËÕÒ½Ò©£¬2009£¬35£¨4£©£º524-526.£¨ÖÐÎĺËÐÄÆÚ¿¯£©
[11]лÒãÇ¿,»ÆÔª»ª,Ðìö©,µÈ.¶àÄÒÂѳ²×ÛºÏÕ÷»¼ÕßÖÐÒ½Ö¤ºòÌصãµÄÑо¿[J].ʱÕä¹úÒ½¹úÒ©£¬2009£¬20£¨5£©£º1205-1207. £¨ÖÐÎĺËÐÄÆÚ¿¯£©